159 related articles for article (PubMed ID: 38275834)
1. Primary Diffuse Leptomeningeal Melanomatosis in a Child with Extracranial Metastasis: Case Report.
Shahab SW; Patil P; Fangusaro JR; Patteson B; Goldman-Yassen A; Eaton BR; Boydston W; Schniederjan M; Aguilera D
Curr Oncol; 2024 Jan; 31(1):579-587. PubMed ID: 38275834
[TBL] [Abstract][Full Text] [Related]
2. Primary central nervous system malignant melanoma with leptomeningeal melanomatosis: a case report and review of the literature.
Fujimori K; Sakai K; Higashiyama F; Oya F; Maejima T; Miyake T
Neurosurg Rev; 2018 Jan; 41(1):333-339. PubMed ID: 28986666
[TBL] [Abstract][Full Text] [Related]
3. NRAS(Q61K) mutated primary leptomeningeal melanoma in a child: case presentation and discussion on clinical and diagnostic implications.
Angelino G; De Pasquale MD; De Sio L; Serra A; Massimi L; De Vito R; Marrazzo A; Lancella L; Carai A; Antonelli M; Giangaspero F; Gessi M; Menchini L; Scarciolla L; Longo D; Mastronuzzi A
BMC Cancer; 2016 Jul; 16():512. PubMed ID: 27439913
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic challenges of primary diffuse leptomeningeal melanomatosis in early adolescence: A case report.
Yamauhci S; Fukuyama T; Inaba Y; Nakajima H; Hattori Y; Miyairi Y; Ogiso Y
Brain Dev; 2022 Jun; 44(6):421-425. PubMed ID: 35260265
[TBL] [Abstract][Full Text] [Related]
5. Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated
Ascierto PA; Mandalà M; Ferrucci PF; Guidoboni M; Rutkowski P; Ferraresi V; Arance A; Guida M; Maiello E; Gogas H; Richtig E; Fierro MT; Lebbè C; Helgadottir H; Queirolo P; Spagnolo F; Tucci M; Del Vecchio M; Gonzales Cao M; Minisini AM; De Placido S; Sanmamed MF; Mallardo D; Curvietto M; Melero I; Palmieri G; Grimaldi AM; Giannarelli D; Dummer R; Chiarion Sileni V
J Clin Oncol; 2023 Jan; 41(2):212-221. PubMed ID: 36049147
[TBL] [Abstract][Full Text] [Related]
6. Primary Diffuse Leptomeningeal Melanomatosis in an Indian Child With Review of Literature.
Kumar A; Gunasekaran PK; Aggarwal D; Janu V; Manjunathan S; Laxmi V; Tiwari S; Saini L
Pediatr Neurol; 2024 Mar; 152():23-29. PubMed ID: 38176225
[TBL] [Abstract][Full Text] [Related]
7. [Primary diffuse meningeal melanomatosis. Case report].
Bajer-Czajkowska A; Nowacki P
Neurol Neurochir Pol; 2007; 41(1):82-8. PubMed ID: 17330185
[TBL] [Abstract][Full Text] [Related]
8. Primary diffuse meningeal melanomatosis: radiologic-pathologic correlation.
Pirini MG; Mascalchi M; Salvi F; Tassinari CA; Zanella L; Bacchini P; Bertoni F; D'Errico A; Corti B; Grigioni WF
AJNR Am J Neuroradiol; 2003 Jan; 24(1):115-8. PubMed ID: 12533338
[TBL] [Abstract][Full Text] [Related]
9. NRAS
Girolami I; Cima L; Ghimenton C; Zannoni M; Mombello A; Riva G; Cirielli V; Corradi G; Vogrig A; Di Stefano G; Novelli L; Gessi M; Eccher A
Brain Tumor Pathol; 2018 Oct; 35(4):217-223. PubMed ID: 30145692
[TBL] [Abstract][Full Text] [Related]
10. Pediatric primary diffuse leptomeningeal melanomatosis: Case report and review of the literature.
Xu X; Zheng Y; Li J; Wang F; Li F
Medicine (Baltimore); 2020 Feb; 99(8):e19178. PubMed ID: 32080099
[TBL] [Abstract][Full Text] [Related]
11. Novel Insights into Diagnosis, Biology and Treatment of Primary Diffuse Leptomeningeal Melanomatosis.
Baumgartner A; Stepien N; Mayr L; Madlener S; Dorfer C; Schmook MT; Traub-Weidinger T; Lötsch-Gojo D; Kirchhofer D; Reisinger D; Hedrich C; Arshad S; Irschik S; Boztug H; Engstler G; Bernkopf M; Rifatbegovic F; Höller C; Slavc I; Berger W; Müllauer L; Haberler C; Azizi AA; Peyrl A; Gojo J
J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33921303
[TBL] [Abstract][Full Text] [Related]
12. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
Afzal MZ; Mabaera R; Shirai K
J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
[TBL] [Abstract][Full Text] [Related]
13. Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES).
Lau PKH; Feran B; Smith L; Lasocki A; Molania R; Smith K; Weppler A; Angel C; Kee D; Bhave P; Lee B; Young RJ; Iravani A; Yeang HA; Vergara IA; Kok D; Drummond K; Neeson PJ; Sheppard KE; Papenfuss T; Solomon BJ; Sandhu S; McArthur GA
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34625515
[TBL] [Abstract][Full Text] [Related]
14. Primary leptomeningeal melanomatosis: early leptomeningeal enhancement on MRI.
Celli P; Acqui M; Trillò G; Ramundo EO; D'Andrea G; Roperto R; Ferrante L
J Neurosurg Sci; 2001 Dec; 45(4):235-40. PubMed ID: 11912478
[TBL] [Abstract][Full Text] [Related]
15. Primary Diffuse Leptomeningeal Melanomatosis: Case Report and Review of the Literature.
Eichberg DG; Achua JK; Locatelli E; Shah AH; Komotar RJ; Ghods AJ
World Neurosurg; 2019 Feb; 122():648-655. PubMed ID: 30496931
[TBL] [Abstract][Full Text] [Related]
16. Malignant Transformation and Leptomeningeal Melanomatosis in a Primary Meningeal Melanocytoma: A Case Report and Review of Literature.
Nakase K; Matsuda R; Okamoto T; Nakagawa I; Takeda M; Sakata K; Nakase H
NMC Case Rep J; 2023; 10():315-320. PubMed ID: 38076394
[TBL] [Abstract][Full Text] [Related]
17. Primary diffuse meningeal melanomatosis - a rare form of meningeal melanoma: case report.
Garbacz T; Osuchowski M; Bartosik-Psujek H
BMC Neurol; 2019 Nov; 19(1):271. PubMed ID: 31690266
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of BRAF/MEK inhibitor-resistant advanced cutaneous melanoma with nivolumab plus ipilimumab combination therapy followed by intensity-modulated radiotherapy.
Okuma T; Furudate S; Kambayashi Y; Hashimoto A; Aiba S; Fujimura T
J Dermatol; 2021 Sep; 48(9):1419-1422. PubMed ID: 34002878
[TBL] [Abstract][Full Text] [Related]
19. A case report of a patient with inoperable primary diffuse leptomeningeal melanomatosis treated with whole-brain radiotherapy and pembrolizumab.
Palacka P; Slopovsky J; Makovnik M; Kajo K; Obertova J; Mego M
Medicine (Baltimore); 2022 Jan; 101(3):e28613. PubMed ID: 35060532
[TBL] [Abstract][Full Text] [Related]
20. Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
Tawbi HA; Forsyth PA; Algazi A; Hamid O; Hodi FS; Moschos SJ; Khushalani NI; Lewis K; Lao CD; Postow MA; Atkins MB; Ernstoff MS; Reardon DA; Puzanov I; Kudchadkar RR; Thomas RP; Tarhini A; Pavlick AC; Jiang J; Avila A; Demelo S; Margolin K
N Engl J Med; 2018 Aug; 379(8):722-730. PubMed ID: 30134131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
